Skip to main content
Premium Trial:

Request an Annual Quote

Agouron Will Establish Division for Oncology

Premium

LA JOLLA, Calif.--Agouron Pharmaceuticals announced its intention to create a separate operating division in which the company's research and development of products for oncology and related fields will be conducted. Under the proposed plan, yet to be approved by shareholders, financial performance of the oncology R&D division would be tracked as separate equity.

Agouron also announced fiscal 1998 net income of $13,154,000, or 40 cents per share, on total revenues of $466,505,000.

Filed under

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.